Follow us
GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Top Page
About Us
R&D
Investor Relations
Sustainability
ESG
Contact Us
[Link to Japanese page]
Latest Information
Read more
08/29/2025
Information
Financial Results Briefing for Q2 FY 2025 (on August 29, 2025)
07/08/2025
Information
Notice regarding Cullgen’s participation in the conference
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(ETUARY)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
IR News
Message
Stock Quote
